Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Megestrol + ibuprofen for cancer cachexia

Oct. 21, 1997

First launch for Yamanouchi bisphosphonate

Oct. 21, 1997

FDA approves Follistim for IVF and ovulation induction

Oct. 17, 1997

Abbott and Biorex to collaborate on bimoclomol development

Oct. 17, 1997

Novel protein tyrosine kinase inhibitors particularly useful for osteoporosis

Oct. 16, 1997

Clinical activity of policosanol reported

Oct. 16, 1997

Niaspan clinical activity reported at atherosclerosis symposium

Oct. 16, 1997

Lipogelosomes: a novel approach to lowering cholesterol

Oct. 16, 1997

Preclinical cholesterol-lowering efficacy described for FR-194738

Oct. 16, 1997

Fujisawa's benzimidazole derivatives have broad therapeutic potential

Oct. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...